Bojestig, M <br/><br/>
Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes.  [electronic resource] 

 -  Diabetes care  May 2001 
 - 919-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.24.5.919  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albuminuria--prevention & control<br/>Angiotensin-Converting Enzyme Inhibitors--adverse effects<br/>Blood Pressure--drug effects<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate--drug effects<br/>Humans<br/>Male<br/>Peptidyl-Dipeptidase A--blood<br/>Placebos<br/>Ramipril--adverse effects<br/>Renin--blood<br/>Single-Blind Method<br/>Time Factors